ERBB2 and breast carcinoma: A systematic review and meta-analysis evaluating AI performance in IHC for breast cancer reported high diagnostic accuracy in distinguishing HER2 expression, with sensitivity ranging from 0.78 to 0.99 and specificity between 0.92 and 0.98, contingent on HER2 status [123].